#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphangiosarcoma Mucopolysaccharidosis I Fibrosarcoma Dementia Hepato-lenticular degeneration Immunodeficiency common variable Alpha-1 antitrypsin deficiency Immune-mediated myositis Biliary neoplasm Hypergammaglobulinaemia benign monoclonal Breast cancer metastatic Epstein-Barr virus infection Autoimmune hepatitis Breast angiosarcoma Oropharyngeal cancer recurrent More trials…

    Learn about Rare Diseases

    Angiosarcoma recurrent Immunodeficiency congenital – Trials in Disease Isodicentric chromosome 15 syndrome – Life with Disease Biotinidase deficiency – Diagnostics Factor VIII deficiency – Trials in Disease Andersen-Tawil syndrome – Trials in Disease KBG syndrome – Basic Information Progressive supranuclear palsy Skin angiosarcoma – Diagnostics Myelodysplastic syndrome with excess blasts – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betaine Citrate Nefopam M-(18F)-Fluorobenzylguanidine Aminocaproic Acid Letrozole Tropicamide Epinephrine Bitartrate Df1001 Sildenafil Citrate Levosimendan Palivizumab 177Lu-Rhpsma-10.1 Capecitabine Streptococcus Agalactiae XELAFASLATIDE Octreotide Anitocabtagene Autoleucel Donepezil Hydrochloride Terlipressin Acetate BI 456906 More therapies…

    Learn about Your Condition

    Polymyalgia rheumatica Essential hypertension Iron deficiency anaemia Obesity Cutaneous calcification Pleural mesothelioma malignant Obstructive airways disorder Small for dates baby Transient ischaemic attack Porphyria non-acute Metastases to rectum Genital herpes simplex Endocrine ophthalmopathy Hypersomnia Vulvovaginal dryness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Psychotic disorder

  • Study on the Effects of GT-002 and Oxazepam for Cognitive Impairment in Schizophrenia Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Schizoaffective disorder
    • Schizophrenia
    • Psychotic disorder
    Investigated Drugs:
    • GT-002
    • Oxazepam
    Denmark

  • Study on ITI-1284 for Treating Psychosis in Alzheimer’s Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Psychotic disorder
    • Dementia Alzheimer’s type
    • Dementia of the Alzheimer’s type with delusions
    Investigated Drugs:
    • Iti-1284
    Bulgaria Croatia Czechia Italy Poland Romania +2

  • Study of Rituximab for Patients with Psychosis or Obsessive-Compulsive Disorder Linked to Immune System Involvement

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Obsessive-compulsive disorder
    • Psychotic disorder
    Investigated Drugs:
    • Rituximab
    Sweden

  • Study on Personalized Dosing of Sertraline, Aripiprazole, and Risperidone for Patients with Mood, Anxiety, or Psychotic Disorders

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Affective disorder
    • Anxiety disorder
    • Psychotic disorder
    Investigated Drugs:
    • Aripiprazole
    • Risperidone
    • Escitalopram
    Germany The Netherlands Spain

  • Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer’s-Related Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psychotic disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Psychotic disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Belgium Bulgaria Croatia France Germany Greece +7
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!